12909273 · Active · incorporated 5 years, 10 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series A
Develops a platform for human rejuvenation, decoding the 'rejuvenation genome' to reverse aging and improve healthspan.
See the complete cap table with every shareholder, founder tags, dilution across 9 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.